Recent Articles

• Optiva Inc. Demonstrates Resilience in Q4 2024 Results
• Teamsters Stand Firm Against United Airlines' Contract Cuts
• GFL Environmental's Financial Moves Show Commitment to Shareholders
• Nicholas DiMeo Joins RadioNemo as New General Manager
• Fostering Resilience in Children Through Trust and Connection
• Richmond American Launches Exciting Community in Goodyear
• Converge Technology Solutions Gains Support for Acquisition
• Guidance for Converge Technology Solutions Shareholders on Vote
• Aurora Cannabis to Share Insights at Global Regulatory Summit
• Sanctuary Medicinals Triumphs at NECANN Cup with Recognition
• Dr. Marco N. Barusco Takes Leadership Role with AACS
• Nouscom Unveils Promising NOUS-209 Results Against Cancer Risk
• Bombardier Defense Strengthens Operations with New Aircraft Order
• New Board Members Enhancing Element Fleet's Leadership
• Exploring Weatherford's Advancements in Their 2024 Digital Report
• ERES Announces Financial Results Release and Conference Call Schedule
• Upcoming CAPREIT Financial Results and Conference Call Details
• Innovative Drug Discoveries by Nurix Therapeutics Unveiled
• Nokia's Strategic Share Repurchase Plans for Future Growth
• W&T Offshore Elevates Huan Gamblin to Key Leadership Role
• Blueberries Medical Secures C$1 Million through Private Placement
• Bicara Therapeutics Set to Showcase Cutting-Edge Research
• CISO Global Strengthens Financial Position with Debt Payoff
• Rinnai Champions American Jobs and Energy Efficiency
• CPKC Files Proxy Circular for Upcoming Shareholder Meeting
• Jonas Brothers To Be Inducted into New Jersey Hall of Fame
• Discover Liquid Web's Innovative Disaster Recovery Solutions
• Affimed Shares Insights on AFM24 at Upcoming AACR Event
• Abpro Presents Promising Preclinical Findings on ABP-102/CT-P72
• NeOnc Technologies: Preparing for Nasdaq Listing with NTHI
• Zymeworks Unveils Innovative Cancer Therapies at AACR Meeting
• Evaxion Showcases EVX-01 Data at the Prestigious AACR Meeting
• Olema Oncology Advances OP-3136 in Promising Cancer Research
• Exciting Updates from Cogent Biosciences at AACR 2025 Event
• Erasca Showcases Innovative Cancer Treatments at AACR Meeting
• Innovative Cancer Vaccine Insights from IO Biotech at AACR 2025
• iTeos Unveils Innovative Items at Upcoming AACR Event
• Foghorn Therapeutics Unveils Promising Data for FHD-909
• Zentalis Pharmaceuticals Showcases Innovations in Cancer Research
• Freddie Mac Releases Key Mortgage Activity Insights
• AerCap Holdings N.V. Unveils $500 Million Subordinated Note Offering
• Zoomd Technologies Achieves Record Growth in 2024 Results
• Innovative Solutions by Kulicke & Soffa for Memory Market Growth
• Innovative Asterion-PW Technology Launch by Kulicke & Soffa
• Velo3D Set to Release Fiscal Year 2024 Results Soon
• Accent Therapeutics Showcases Innovative Cancer Treatments
• Health In Tech Partners with DialCare for Enhanced Virtual Care
• Detailed Insights on Cadence Bank's Upcoming Earnings Webcast
• CGI Strengthens Its Position in Québec City through Strategic Acquisition
• Rgenta Therapeutics Shines at Upcoming AACR Annual Meeting